{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:05:05Z","timestamp":1787241905768,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"University of Turku Doctoral Programme of Clinical Investigation"},{"DOI":"10.13039\/100010746","name":"Finnish Dermatological Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010746","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011797","name":"Turku University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006383","name":"Cancer Society of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006383","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003125","name":"Finnish Cultural Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-017-0756-4","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T07:29:26Z","timestamp":1516001366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study"],"prefix":"10.1186","volume":"13","author":[{"given":"Jussi","family":"Lepp\u00e4virta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roope A.","family":"Kallionp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Uusitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero","family":"Vahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"P\u00f6yh\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkku","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"key":"756_CR1","doi-asserted-by":"crossref","unstructured":"Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol. 2011;178:1932\u20139.","DOI":"10.1016\/j.ajpath.2010.12.056"},{"key":"756_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","volume":"6","author":"RE Ferner","year":"2007","unstructured":"Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007;6:340\u201351.","journal-title":"Lancet Neurol"},{"key":"756_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","volume":"89","author":"JM Friedman","year":"1999","unstructured":"Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89:1\u20136.","journal-title":"Am J Med Genet"},{"key":"756_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/jid.2014.465","volume":"135","author":"E Uusitalo","year":"2015","unstructured":"Uusitalo E, Lepp\u00e4virta J, Koffert A, Suominen S, Vahtera J, Vahlberg T, et al. Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol. 2015;135:904\u20136.","journal-title":"J Invest Dermatol"},{"key":"756_CR5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/jmg.37.8.632","volume":"37","author":"M Poyhonen","year":"2000","unstructured":"Poyhonen M. Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland. J Med Genet. 2000;37:632\u20136.","journal-title":"J Med Genet"},{"key":"756_CR6","first-page":"160","volume":"77","author":"K McKeever","year":"2008","unstructured":"McKeever K, Shepherd CW, Crawford H, Morrison PJ. An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age. Ulster Med J. 2008;77:160\u20133.","journal-title":"Ulster Med J"},{"key":"756_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/jmg.26.11.704","volume":"26","author":"SM Huson","year":"1989","unstructured":"Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet. 1989;26:704\u201311.","journal-title":"J Med Genet"},{"key":"756_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archderm.141.1.71","volume":"141","author":"M Lammert","year":"2005","unstructured":"Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 2005;141:71\u20134.","journal-title":"Arch Dermatol"},{"key":"756_CR9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1002\/jbmr.1685","volume":"27","author":"E Heerv\u00e4","year":"2012","unstructured":"Heerv\u00e4 E, Koffert A, Jokinen E, Kuorilehto T, Peltonen S, Aro HT, et al. A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age. J Bone Miner Res. 2012;27:2333\u20137.","journal-title":"J Bone Miner Res"},{"key":"756_CR10","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1177\/0883073808316366","volume":"23","author":"LC Krab","year":"2008","unstructured":"Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA, et al. Impact of neurofibromatosis type 1 on school performance. J Child Neurol. 2008;23:1002\u201310.","journal-title":"J Child Neurol"},{"key":"756_CR11","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/ajmg.a.38372","volume":"173","author":"J Lepp\u00e4virta","year":"2017","unstructured":"Lepp\u00e4virta J, Kallionp\u00e4\u00e4 RA, Uusitalo E, Vahlberg T, P\u00f6yh\u00f6nen M, Timonen S, et al. The pregnancy in neurofibromatosis 1: a retrospective register-based total population study. Am. J. Med. Genet. Part A. 2017;173:2641\u20138.","journal-title":"Am. J. Med. Genet. Part A."},{"key":"756_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0","volume":"95","author":"AE Lin","year":"2000","unstructured":"Lin AE, Birch PH, Korf BR, Tenconi R, Niimura M, Poyhonen M, et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet. 2000;95:108\u201317.","journal-title":"Am J Med Genet"},{"key":"756_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00125817-200205000-00002","volume":"4","author":"JM Friedman","year":"2002","unstructured":"Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, et al. Cardiovascular disease in neurofibromatosis 1: report of the NF1 cardiovascular task force. Genet Med. 2002;4:105\u201311.","journal-title":"Genet Med"},{"key":"756_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ajmg.a.33178","volume":"152A","author":"L Alivuotila","year":"2010","unstructured":"Alivuotila L, Hakokari J, Visnapuu V, Korpijaakko-Huuhka A-M, Aaltonen O, Happonen R-P, et al. Speech characteristics in neurofibromatosis type 1. Am J Med Genet A. 2010;152A:42\u201351.","journal-title":"Am J Med Genet A"},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionp\u00e4\u00e4 RA, P\u00f6yh\u00f6nen M, Lepp\u00e4virta J, Yl\u00e4-Outinen H, et al. Distinctive cancer associations in patients with Neurofibromatosis type 1. J Clin Oncol. 2016;34:1978\u201386.","journal-title":"J Clin Oncol"},{"key":"756_CR16","unstructured":"Neurofibromatosis. Conference statement. National Institutes of Health consensus development conference. Arch Neurol. 1988;45:575\u20138."},{"key":"756_CR17","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Prim. 2017;3:17004.","journal-title":"Nat Rev Dis Prim"},{"key":"756_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/aja.1001950307","volume":"195","author":"MM Daston","year":"1992","unstructured":"Daston MM, Ratner N. Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev Dyn. 1992;195:216\u201326.","journal-title":"Dev Dyn"},{"key":"756_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ajmg.c.30296","volume":"157","author":"DA Stevenson","year":"2011","unstructured":"Stevenson DA, Yang F-C. The musculoskeletal phenotype of the RASopathies. Am J Med Genet Part C Semin Med Genet. 2011;157:90\u2013103.","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"key":"756_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1101\/gad.8.9.1019","volume":"8","author":"CI Brannan","year":"1994","unstructured":"Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 1994;8:1019\u201329.","journal-title":"Genes Dev"},{"key":"756_CR21","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1523\/JNEUROSCI.4693-04.2005","volume":"25","author":"B Dasgupta","year":"2005","unstructured":"Dasgupta B, Gutmann DH. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. J Neurosci. 2005;25:5584\u201394.","journal-title":"J Neurosci"},{"key":"756_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jvs.2007.03.055","volume":"46","author":"GS Oderich","year":"2007","unstructured":"Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV, Babovic-Vuksanovic D, et al. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg. 2007;46:475\u201384.","journal-title":"J Vasc Surg"},{"key":"756_CR23","first-page":"301","volume":"19","author":"M Ruggieri","year":"1999","unstructured":"Ruggieri M, Pavone V, De Luca D, Franz\u00f2 A, Tin\u00e9 A, Pavone L. Congenital bone malformations in patients with neurofibromatosis type 1 (Nf1). J Pediatr Orthop. 1999;19:301\u20135.","journal-title":"J Pediatr Orthop"},{"key":"756_CR24","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1002\/ajmg.a.36737","volume":"164","author":"A Myers","year":"2014","unstructured":"Myers A, Bernstein JA, Brennan M-L, Curry C, Esplin ED, Fisher J, et al. Perinatal features of the RASopathies: Noonan syndrome, Cardiofaciocutaneous syndrome and Costello syndrome. Am J Med Genet Part A. 2014;164:2814\u201321.","journal-title":"Am J Med Genet Part A"},{"key":"756_CR25","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1002\/bdra.20775","volume":"91","author":"R Greenlees","year":"2011","unstructured":"Greenlees R, Neville A, Addor M-C, Amar E, Arriola L, Bakker M, et al. Paper 6: EUROCAT member registries: organization and activities. Birth Defects Res Part A Clin Mol Teratol. 2011;91:S51\u2013100.","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"756_CR26","unstructured":"EUROCAT Association. Coding of EUROCAT subgroups of congenital anomalies [internet]. EUROCAT guide 1.4. 2014. Available from: http:\/\/www.eurocat-network.eu\/content\/Section%203.3-%2027_Oct2016.pdf . Accessed 11 July 2017."},{"key":"756_CR27","doi-asserted-by":"crossref","unstructured":"Teperi J. Multi method approach to the assessment of data quality in the Finnish medical birth registry. J Epidemiol Community Health. 1993;47:242\u20137.","DOI":"10.1136\/jech.47.3.242"},{"key":"756_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/14639230110119234","volume":"27","author":"M Gissler","year":"2002","unstructured":"Gissler M, Shelley J. Quality of data on subsequent events in a routine medical birth register. Med Inform Internet Med. 2002;27:33\u20138.","journal-title":"Med Inform Internet Med"},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1542\/peds.105.3.608","volume":"105","author":"K DeBella","year":"2000","unstructured":"DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105:608\u201314.","journal-title":"Pediatrics"},{"key":"756_CR30","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1210\/jc.2006-2017","volume":"92","author":"PE Clayton","year":"2007","unstructured":"Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A. Management of the child born small for gestational age through to adulthood: a consensus statement of the international societies of pediatric endocrinology and the growth hormone research society. J Clin Endocrinol Metab. 2007;92:804\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"756_CR31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/07853890.2013.803739","volume":"45","author":"U Sankilampi","year":"2013","unstructured":"Sankilampi U, Hannila M-L, Saari A, Gissler M, Dunkel L. New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann Med. 2013;45:446\u201354.","journal-title":"Ann Med"},{"key":"756_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1067\/mhj.2002.122121","volume":"143","author":"MA Tedesco","year":"2002","unstructured":"Tedesco MA, Di Salvo G, Natale F, Pergola V, Calabrese E, Grassia C, et al. The heart in neurofibromatosis type 1: an echocardiographic study. Am Heart J. 2002;143:883\u20138.","journal-title":"Am Heart J"},{"key":"756_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijcard.2017.07.068","volume":"245","author":"G Calcagni","year":"2017","unstructured":"Calcagni G, Limongelli G, D\u2019Ambrosio A, Gesualdo F, Digilio MC, Baban A, et al. Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results. Int J Cardiol. 2017;245:92\u20138.","journal-title":"Int J Cardiol"},{"key":"756_CR34","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1212\/WNL.50.6.1755","volume":"50","author":"JH Tonsgard","year":"1998","unstructured":"Tonsgard JH, Kwak SM, Short MP, Dachman AH. CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology. 1998;50:1755\u201360.","journal-title":"Neurology"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0756-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T06:42:19Z","timestamp":1570603339000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0756-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0756-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]},"assertion":[{"value":"3 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study complied with the Declaration of Helsinki and the protocol of the study was approved by the Ethics Committee of the Hospital District of Southwest Finland. Permissions to run the study were obtained from the National Institute for Health and Welfare, and from secondary and tertiary referral centers in Finland. Consent to participate was not needed, since patients were not contacted during data collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"5"}}